Back
Cartesian Therapeutics Stock Predictions

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
35
RNAC
Cartesian Therapeutics
Last Price:
$11.45
Seasonality Move:
1.03%
7 Day Trial
ALL ACCESS PASS
$
7

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaCartesian Therapeutics Stock Forecast
-
Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 13.9% based on the past 9 years of stock performance.
-
Cartesian Therapeutics has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Cartesian Therapeutics Stock Undervalued?The current Cartesian Therapeutics [RNAC] share price is $10.76. The Score for RNAC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cartesian Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 13.9% based on the past 9 years of stock performance.
Cartesian Therapeutics Stock Rating
Sell
35
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics overpriced?
-
Cartesian Therapeutics has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Cartesian Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cartesiantherapeutics.com
52-Week Data
52-Week High:
29.65
52-Week Low:
8.46
Prediction Charts
Market Cap:
279.3M
Price in USD:
10.76
Volume:
57.6K
Beta:
0.85
Technical Analysis
SMA50:
10.56
SMA100:
13.48
SMA200:
16.32
52-Wk Change:
-55.28%
Stock Predictions
-
Is Cartesian Therapeutics stock public?Yes, Cartesian Therapeutics is a publicly traded company.
-
What is the Cartesian Therapeutics stock quote today?The Cartesian Therapeutics stock price is 10.76 USD today.
-
How to buy Cartesian Therapeutics stock online?You can buy Cartesian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-5 | 9.55 | 9.34 | 9.55 | 9.01 |
Jun-6 | 9.42 | 11.04 | 11.12 | 9.18 |
Jun-9 | 11.43 | 10.85 | 11.48 | 10.50 |
Jun-10 | 10.90 | 10.77 | 11.31 | 10.51 |
Jun-11 | 11.04 | 10.41 | 11.26 | 10.41 |
Jun-12 | 10.27 | 10.24 | 10.32 | 9.90 |
Jun-13 | 10.02 | 10.42 | 10.44 | 10.02 |
Jun-16 | 10.20 | 10.32 | 10.43 | 10.04 |
Jun-17 | 10.25 | 9.79 | 10.56 | 9.77 |
Jun-18 | 9.82 | 10.00 | 10.40 | 9.72 |
Jun-20 | 10.07 | 9.76 | 10.11 | 9.63 |
Jun-23 | 9.68 | 9.83 | 9.91 | 9.37 |
Jun-24 | 9.87 | 10.36 | 10.40 | 9.78 |
Jun-25 | 10.33 | 10.76 | 10.87 | 10.15 |
Cartesian Therapeutics Earnings
Cartesian Therapeutics Earnings Report: Per Share Cartesian Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cartesian Therapeutics Forecast Revenue Growth
Cartesian Therapeutics Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $1.95 per share.
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.